PEXIOVEQ
Live / Applied — Fourth extension granted (statement of use) (as of 05 Dec 2025)
What this means for you
Not registered yet, but its 29 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97695576
- Mark type
- Stylized text
- Filed
- 29 Nov 2022
- Published for opposition
- 17 Oct 2023
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
- Class 042 — Scientific and technological services: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
Owner
- SillaJen, Inc., Seoul, KR
- SillaJen, Inc., Seoul, KR
Prosecution history
- 05 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2025 — SOU EXTENSION 4 GRANTED
- 05 Dec 2025 — SOU EXTENSION 4 FILED
- 05 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 3 GRANTED
- 16 May 2025 — SOU EXTENSION 3 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 2 GRANTED
- 06 Dec 2024 — SOU EXTENSION 2 FILED
- 06 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2024 — SOU EXTENSION 1 GRANTED
- 12 Jun 2024 — SOU EXTENSION 1 FILED